カテゴリー： 世界, 部品/材料, QYResearch

L-ドーパの世界市場インサイト・予測（～2028年）

【英語タイトル】Global L-Dopa Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX01363）・商品コード：QY22JLX01363
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：114
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、L-ドーパのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にL-ドーパの世界市場のxxx％を占める「純度：98％」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「パーキンソン病医薬品」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
L-ドーパの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのL-ドーパ市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

L-ドーパのグローバル主要企業には、Ajinomoto、Daiichi Sankyo、Divis Laboratories、Tiefenbacher API + Ingredients、Teva Pharmaceutical Industries、Xinhua Pharmaceutical、Zhejiang Huahai Pharmaceutical、Zhejiang Wild Wind Pharmaceutical、JL Pharm、ChenLv Herbなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

L-ドーパ市場は、種類と用途によって区分されます。世界のL-ドーパ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
純度：98％、純度：99％

【用途別セグメント】
パーキンソン病医薬品、肝性脳症医薬品、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- L-ドーパ製品概要
- 種類別市場（純度：98％、純度：99％）
- 用途別市場（パーキンソン病医薬品、肝性脳症医薬品、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のL-ドーパ販売量予測2017-2028
- 世界のL-ドーパ売上予測2017-2028
- L-ドーパの地域別販売量
- L-ドーパの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別L-ドーパ販売量
- 主要メーカー別L-ドーパ売上
- 主要メーカー別L-ドーパ価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（純度：98％、純度：99％）
- L-ドーパの種類別販売量
- L-ドーパの種類別売上
- L-ドーパの種類別価格
・用途別市場規模（パーキンソン病医薬品、肝性脳症医薬品、その他）
- L-ドーパの用途別販売量
- L-ドーパの用途別売上
- L-ドーパの用途別価格
・北米市場
- 北米のL-ドーパ市場規模（種類別、用途別）
- 主要国別のL-ドーパ市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのL-ドーパ市場規模（種類別、用途別）
- 主要国別のL-ドーパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のL-ドーパ市場規模（種類別、用途別）
- 主要国別のL-ドーパ市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のL-ドーパ市場規模（種類別、用途別）
- 主要国別のL-ドーパ市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのL-ドーパ市場規模（種類別、用途別）
- 主要国別のL-ドーパ市場規模（トルコ、サウジアラビア）
・企業情報
Ajinomoto、Daiichi Sankyo、Divis Laboratories、Tiefenbacher API + Ingredients、Teva Pharmaceutical Industries、Xinhua Pharmaceutical、Zhejiang Huahai Pharmaceutical、Zhejiang Wild Wind Pharmaceutical、JL Pharm、ChenLv Herb
・産業チェーン及び販売チャネル分析
- L-ドーパの産業チェーン分析
- L-ドーパの原材料
- L-ドーパの生産プロセス
- L-ドーパの販売及びマーケティング
- L-ドーパの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- L-ドーパの産業動向
- L-ドーパのマーケットドライバー
- L-ドーパの課題
- L-ドーパの阻害要因
・主な調査結果

L-Dopa is the prodrug of dopamine (DA), which has no pharmacological activity itself, enters the center through the blood-brain barrier, and is converted into DA by the action of dopa decarboxylase to exert pharmacological effects.
Market Analysis and Insights: Global L-Dopa Market
Due to the COVID-19 pandemic, the global L-Dopa market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity: 98% accounting for % of the L-Dopa global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Parkinson Disease Medicine segment is altered to an % CAGR throughout this forecast period.
China L-Dopa market size is valued at US$ million in 2021, while the US and Europe L-Dopa are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe L-Dopa landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of L-Dopa include Ajinomoto, Daiichi Sankyo, Divis Laboratories, Tiefenbacher API + Ingredients, Teva Pharmaceutical Industries, Xinhua Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Wild Wind Pharmaceutical and JL Pharm and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the L-Dopa capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of L-Dopa by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global L-Dopa Scope and Segment
L-Dopa market is segmented by Type and by Application. Players, stakeholders, and other participants in the global L-Dopa market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity: 98%
Purity: 99%
Segment by Application
Parkinson Disease Medicine
Hepatic Encephalopathy Medicine
Others
By Company
Ajinomoto
Daiichi Sankyo
Divis Laboratories
Tiefenbacher API + Ingredients
Teva Pharmaceutical Industries
Xinhua Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Wild Wind Pharmaceutical
JL Pharm
ChenLv Herb
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 L-Dopa Product Introduction
1.2 Market by Type
1.2.1 Global L-Dopa Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity: 98%
1.2.3 Purity: 99%
1.3 Market by Application
1.3.1 Global L-Dopa Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Parkinson Disease Medicine
1.3.3 Hepatic Encephalopathy Medicine
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global L-Dopa Production
2.1 Global L-Dopa Production Capacity (2017-2028)
2.2 Global L-Dopa Production by Region: 2017 VS 2021 VS 2028
2.3 Global L-Dopa Production by Region
2.3.1 Global L-Dopa Historic Production by Region (2017-2022)
2.3.2 Global L-Dopa Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global L-Dopa Sales in Volume & Value Estimates and Forecasts
3.1 Global L-Dopa Sales Estimates and Forecasts 2017-2028
3.2 Global L-Dopa Revenue Estimates and Forecasts 2017-2028
3.3 Global L-Dopa Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global L-Dopa Sales by Region
3.4.1 Global L-Dopa Sales by Region (2017-2022)
3.4.2 Global Sales L-Dopa by Region (2023-2028)
3.5 Global L-Dopa Revenue by Region
3.5.1 Global L-Dopa Revenue by Region (2017-2022)
3.5.2 Global L-Dopa Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global L-Dopa Production Capacity by Manufacturers
4.2 Global L-Dopa Sales by Manufacturers
4.2.1 Global L-Dopa Sales by Manufacturers (2017-2022)
4.2.2 Global L-Dopa Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of L-Dopa in 2021
4.3 Global L-Dopa Revenue by Manufacturers
4.3.1 Global L-Dopa Revenue by Manufacturers (2017-2022)
4.3.2 Global L-Dopa Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by L-Dopa Revenue in 2021
4.4 Global L-Dopa Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global L-Dopa Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global L-Dopa Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global L-Dopa Sales by Type
5.1.1 Global L-Dopa Historical Sales by Type (2017-2022)
5.1.2 Global L-Dopa Forecasted Sales by Type (2023-2028)
5.1.3 Global L-Dopa Sales Market Share by Type (2017-2028)
5.2 Global L-Dopa Revenue by Type
5.2.1 Global L-Dopa Historical Revenue by Type (2017-2022)
5.2.2 Global L-Dopa Forecasted Revenue by Type (2023-2028)
5.2.3 Global L-Dopa Revenue Market Share by Type (2017-2028)
5.3 Global L-Dopa Price by Type
5.3.1 Global L-Dopa Price by Type (2017-2022)
5.3.2 Global L-Dopa Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global L-Dopa Sales by Application
6.1.1 Global L-Dopa Historical Sales by Application (2017-2022)
6.1.2 Global L-Dopa Forecasted Sales by Application (2023-2028)
6.1.3 Global L-Dopa Sales Market Share by Application (2017-2028)
6.2 Global L-Dopa Revenue by Application
6.2.1 Global L-Dopa Historical Revenue by Application (2017-2022)
6.2.2 Global L-Dopa Forecasted Revenue by Application (2023-2028)
6.2.3 Global L-Dopa Revenue Market Share by Application (2017-2028)
6.3 Global L-Dopa Price by Application
6.3.1 Global L-Dopa Price by Application (2017-2022)
6.3.2 Global L-Dopa Price Forecast by Application (2023-2028)
7 North America
7.1 North America L-Dopa Market Size by Type
7.1.1 North America L-Dopa Sales by Type (2017-2028)
7.1.2 North America L-Dopa Revenue by Type (2017-2028)
7.2 North America L-Dopa Market Size by Application
7.2.1 North America L-Dopa Sales by Application (2017-2028)
7.2.2 North America L-Dopa Revenue by Application (2017-2028)
7.3 North America L-Dopa Sales by Country
7.3.1 North America L-Dopa Sales by Country (2017-2028)
7.3.2 North America L-Dopa Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe L-Dopa Market Size by Type
8.1.1 Europe L-Dopa Sales by Type (2017-2028)
8.1.2 Europe L-Dopa Revenue by Type (2017-2028)
8.2 Europe L-Dopa Market Size by Application
8.2.1 Europe L-Dopa Sales by Application (2017-2028)
8.2.2 Europe L-Dopa Revenue by Application (2017-2028)
8.3 Europe L-Dopa Sales by Country
8.3.1 Europe L-Dopa Sales by Country (2017-2028)
8.3.2 Europe L-Dopa Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific L-Dopa Market Size by Type
9.1.1 Asia Pacific L-Dopa Sales by Type (2017-2028)
9.1.2 Asia Pacific L-Dopa Revenue by Type (2017-2028)
9.2 Asia Pacific L-Dopa Market Size by Application
9.2.1 Asia Pacific L-Dopa Sales by Application (2017-2028)
9.2.2 Asia Pacific L-Dopa Revenue by Application (2017-2028)
9.3 Asia Pacific L-Dopa Sales by Region
9.3.1 Asia Pacific L-Dopa Sales by Region (2017-2028)
9.3.2 Asia Pacific L-Dopa Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America L-Dopa Market Size by Type
10.1.1 Latin America L-Dopa Sales by Type (2017-2028)
10.1.2 Latin America L-Dopa Revenue by Type (2017-2028)
10.2 Latin America L-Dopa Market Size by Application
10.2.1 Latin America L-Dopa Sales by Application (2017-2028)
10.2.2 Latin America L-Dopa Revenue by Application (2017-2028)
10.3 Latin America L-Dopa Sales by Country
10.3.1 Latin America L-Dopa Sales by Country (2017-2028)
10.3.2 Latin America L-Dopa Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa L-Dopa Market Size by Type
11.1.1 Middle East and Africa L-Dopa Sales by Type (2017-2028)
11.1.2 Middle East and Africa L-Dopa Revenue by Type (2017-2028)
11.2 Middle East and Africa L-Dopa Market Size by Application
11.2.1 Middle East and Africa L-Dopa Sales by Application (2017-2028)
11.2.2 Middle East and Africa L-Dopa Revenue by Application (2017-2028)
11.3 Middle East and Africa L-Dopa Sales by Country
11.3.1 Middle East and Africa L-Dopa Sales by Country (2017-2028)
11.3.2 Middle East and Africa L-Dopa Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Ajinomoto
12.1.1 Ajinomoto Corporation Information
12.1.2 Ajinomoto Overview
12.1.3 Ajinomoto L-Dopa Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Ajinomoto L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Ajinomoto Recent Developments
12.2 Daiichi Sankyo
12.2.1 Daiichi Sankyo Corporation Information
12.2.2 Daiichi Sankyo Overview
12.2.3 Daiichi Sankyo L-Dopa Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Daiichi Sankyo L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Daiichi Sankyo Recent Developments
12.3 Divis Laboratories
12.3.1 Divis Laboratories Corporation Information
12.3.2 Divis Laboratories Overview
12.3.3 Divis Laboratories L-Dopa Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Divis Laboratories L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Divis Laboratories Recent Developments
12.4 Tiefenbacher API + Ingredients
12.4.1 Tiefenbacher API + Ingredients Corporation Information
12.4.2 Tiefenbacher API + Ingredients Overview
12.4.3 Tiefenbacher API + Ingredients L-Dopa Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Tiefenbacher API + Ingredients L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Tiefenbacher API + Ingredients Recent Developments
12.5 Teva Pharmaceutical Industries
12.5.1 Teva Pharmaceutical Industries Corporation Information
12.5.2 Teva Pharmaceutical Industries Overview
12.5.3 Teva Pharmaceutical Industries L-Dopa Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Teva Pharmaceutical Industries L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Teva Pharmaceutical Industries Recent Developments
12.6 Xinhua Pharmaceutical
12.6.1 Xinhua Pharmaceutical Corporation Information
12.6.2 Xinhua Pharmaceutical Overview
12.6.3 Xinhua Pharmaceutical L-Dopa Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Xinhua Pharmaceutical L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Xinhua Pharmaceutical Recent Developments
12.7 Zhejiang Huahai Pharmaceutical
12.7.1 Zhejiang Huahai Pharmaceutical Corporation Information
12.7.2 Zhejiang Huahai Pharmaceutical Overview
12.7.3 Zhejiang Huahai Pharmaceutical L-Dopa Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Zhejiang Huahai Pharmaceutical L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Zhejiang Huahai Pharmaceutical Recent Developments
12.8 Zhejiang Wild Wind Pharmaceutical
12.8.1 Zhejiang Wild Wind Pharmaceutical Corporation Information
12.8.2 Zhejiang Wild Wind Pharmaceutical Overview
12.8.3 Zhejiang Wild Wind Pharmaceutical L-Dopa Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Zhejiang Wild Wind Pharmaceutical L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Zhejiang Wild Wind Pharmaceutical Recent Developments
12.9 JL Pharm
12.9.1 JL Pharm Corporation Information
12.9.2 JL Pharm Overview
12.9.3 JL Pharm L-Dopa Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 JL Pharm L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 JL Pharm Recent Developments
12.10 ChenLv Herb
12.10.1 ChenLv Herb Corporation Information
12.10.2 ChenLv Herb Overview
12.10.3 ChenLv Herb L-Dopa Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 ChenLv Herb L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 ChenLv Herb Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 L-Dopa Industry Chain Analysis
13.2 L-Dopa Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 L-Dopa Production Mode & Process
13.4 L-Dopa Sales and Marketing
13.4.1 L-Dopa Sales Channels
13.4.2 L-Dopa Distributors
13.5 L-Dopa Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 L-Dopa Industry Trends
14.2 L-Dopa Market Drivers
14.3 L-Dopa Market Challenges
14.4 L-Dopa Market Restraints
15 Key Finding in The Global L-Dopa Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global L-Dopa Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Purity: 98%
Table 3. Major Manufacturers of Purity: 99%
Table 4. Global L-Dopa Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global L-Dopa Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 6. Global L-Dopa Production by Region (2017-2022) & (Tons)
Table 7. Global L-Dopa Production Market Share by Region (2017-2022)
Table 8. Global L-Dopa Production by Region (2023-2028) & (Tons)
Table 9. Global L-Dopa Production Market Share by Region (2023-2028)
Table 10. Global L-Dopa Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global L-Dopa Sales by Region (2017-2022) & (Tons)
Table 12. Global L-Dopa Sales Market Share by Region (2017-2022)
Table 13. Global L-Dopa Sales by Region (2023-2028) & (Tons)
Table 14. Global L-Dopa Sales Market Share by Region (2023-2028)
Table 15. Global L-Dopa Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global L-Dopa Revenue Market Share by Region (2017-2022)
Table 17. Global L-Dopa Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global L-Dopa Revenue Market Share by Region (2023-2028)
Table 19. Global L-Dopa Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 20. Global L-Dopa Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global L-Dopa Sales by Manufacturers (2017-2022) & (Tons)
Table 22. Global L-Dopa Sales Market Share by Manufacturers (2017-2022)
Table 23. Global L-Dopa Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global L-Dopa Revenue Share by Manufacturers (2017-2022)
Table 25. L-Dopa Price by Manufacturers 2017-2022 (US$/Ton)
Table 26. Global L-Dopa Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global L-Dopa by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in L-Dopa as of 2021)
Table 28. L-Dopa Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers L-Dopa Product Offered
Table 30. Date of Manufacturers Enter into L-Dopa Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global L-Dopa Sales by Type (2017-2022) & (Tons)
Table 33. Global L-Dopa Sales by Type (2023-2028) & (Tons)
Table 34. Global L-Dopa Sales Share by Type (2017-2022)
Table 35. Global L-Dopa Sales Share by Type (2023-2028)
Table 36. Global L-Dopa Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global L-Dopa Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global L-Dopa Revenue Share by Type (2017-2022)
Table 39. Global L-Dopa Revenue Share by Type (2023-2028)
Table 40. L-Dopa Price by Type (2017-2022) & (US$/Ton)
Table 41. Global L-Dopa Price Forecast by Type (2023-2028) & (US$/Ton)
Table 42. Global L-Dopa Sales by Application (2017-2022) & (Tons)
Table 43. Global L-Dopa Sales by Application (2023-2028) & (Tons)
Table 44. Global L-Dopa Sales Share by Application (2017-2022)
Table 45. Global L-Dopa Sales Share by Application (2023-2028)
Table 46. Global L-Dopa Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global L-Dopa Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global L-Dopa Revenue Share by Application (2017-2022)
Table 49. Global L-Dopa Revenue Share by Application (2023-2028)
Table 50. L-Dopa Price by Application (2017-2022) & (US$/Ton)
Table 51. Global L-Dopa Price Forecast by Application (2023-2028) & (US$/Ton)
Table 52. North America L-Dopa Sales by Type (2017-2022) & (Tons)
Table 53. North America L-Dopa Sales by Type (2023-2028) & (Tons)
Table 54. North America L-Dopa Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America L-Dopa Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America L-Dopa Sales by Application (2017-2022) & (Tons)
Table 57. North America L-Dopa Sales by Application (2023-2028) & (Tons)
Table 58. North America L-Dopa Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America L-Dopa Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America L-Dopa Sales by Country (2017-2022) & (Tons)
Table 61. North America L-Dopa Sales by Country (2023-2028) & (Tons)
Table 62. North America L-Dopa Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America L-Dopa Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe L-Dopa Sales by Type (2017-2022) & (Tons)
Table 65. Europe L-Dopa Sales by Type (2023-2028) & (Tons)
Table 66. Europe L-Dopa Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe L-Dopa Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe L-Dopa Sales by Application (2017-2022) & (Tons)
Table 69. Europe L-Dopa Sales by Application (2023-2028) & (Tons)
Table 70. Europe L-Dopa Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe L-Dopa Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe L-Dopa Sales by Country (2017-2022) & (Tons)
Table 73. Europe L-Dopa Sales by Country (2023-2028) & (Tons)
Table 74. Europe L-Dopa Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe L-Dopa Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific L-Dopa Sales by Type (2017-2022) & (Tons)
Table 77. Asia Pacific L-Dopa Sales by Type (2023-2028) & (Tons)
Table 78. Asia Pacific L-Dopa Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific L-Dopa Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific L-Dopa Sales by Application (2017-2022) & (Tons)
Table 81. Asia Pacific L-Dopa Sales by Application (2023-2028) & (Tons)
Table 82. Asia Pacific L-Dopa Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific L-Dopa Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific L-Dopa Sales by Region (2017-2022) & (Tons)
Table 85. Asia Pacific L-Dopa Sales by Region (2023-2028) & (Tons)
Table 86. Asia Pacific L-Dopa Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific L-Dopa Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America L-Dopa Sales by Type (2017-2022) & (Tons)
Table 89. Latin America L-Dopa Sales by Type (2023-2028) & (Tons)
Table 90. Latin America L-Dopa Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America L-Dopa Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America L-Dopa Sales by Application (2017-2022) & (Tons)
Table 93. Latin America L-Dopa Sales by Application (2023-2028) & (Tons)
Table 94. Latin America L-Dopa Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America L-Dopa Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America L-Dopa Sales by Country (2017-2022) & (Tons)
Table 97. Latin America L-Dopa Sales by Country (2023-2028) & (Tons)
Table 98. Latin America L-Dopa Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America L-Dopa Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa L-Dopa Sales by Type (2017-2022) & (Tons)
Table 101. Middle East and Africa L-Dopa Sales by Type (2023-2028) & (Tons)
Table 102. Middle East and Africa L-Dopa Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa L-Dopa Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa L-Dopa Sales by Application (2017-2022) & (Tons)
Table 105. Middle East and Africa L-Dopa Sales by Application (2023-2028) & (Tons)
Table 106. Middle East and Africa L-Dopa Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa L-Dopa Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa L-Dopa Sales by Country (2017-2022) & (Tons)
Table 109. Middle East and Africa L-Dopa Sales by Country (2023-2028) & (Tons)
Table 110. Middle East and Africa L-Dopa Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa L-Dopa Revenue by Country (2023-2028) & (US$ Million)
Table 112. Ajinomoto Corporation Information
Table 113. Ajinomoto Description and Major Businesses
Table 114. Ajinomoto L-Dopa Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. Ajinomoto L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Ajinomoto Recent Development
Table 117. Daiichi Sankyo Corporation Information
Table 118. Daiichi Sankyo Description and Major Businesses
Table 119. Daiichi Sankyo L-Dopa Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. Daiichi Sankyo L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Daiichi Sankyo Recent Development
Table 122. Divis Laboratories Corporation Information
Table 123. Divis Laboratories Description and Major Businesses
Table 124. Divis Laboratories L-Dopa Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. Divis Laboratories L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Divis Laboratories Recent Development
Table 127. Tiefenbacher API + Ingredients Corporation Information
Table 128. Tiefenbacher API + Ingredients Description and Major Businesses
Table 129. Tiefenbacher API + Ingredients L-Dopa Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 130. Tiefenbacher API + Ingredients L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Tiefenbacher API + Ingredients Recent Development
Table 132. Teva Pharmaceutical Industries Corporation Information
Table 133. Teva Pharmaceutical Industries Description and Major Businesses
Table 134. Teva Pharmaceutical Industries L-Dopa Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 135. Teva Pharmaceutical Industries L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Teva Pharmaceutical Industries Recent Development
Table 137. Xinhua Pharmaceutical Corporation Information
Table 138. Xinhua Pharmaceutical Description and Major Businesses
Table 139. Xinhua Pharmaceutical L-Dopa Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 140. Xinhua Pharmaceutical L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Xinhua Pharmaceutical Recent Development
Table 142. Zhejiang Huahai Pharmaceutical Corporation Information
Table 143. Zhejiang Huahai Pharmaceutical Description and Major Businesses
Table 144. Zhejiang Huahai Pharmaceutical L-Dopa Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 145. Zhejiang Huahai Pharmaceutical L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Zhejiang Huahai Pharmaceutical Recent Development
Table 147. Zhejiang Wild Wind Pharmaceutical Corporation Information
Table 148. Zhejiang Wild Wind Pharmaceutical Description and Major Businesses
Table 149. Zhejiang Wild Wind Pharmaceutical L-Dopa Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 150. Zhejiang Wild Wind Pharmaceutical L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Zhejiang Wild Wind Pharmaceutical Recent Development
Table 152. JL Pharm Corporation Information
Table 153. JL Pharm Description and Major Businesses
Table 154. JL Pharm L-Dopa Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 155. JL Pharm L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. JL Pharm Recent Development
Table 157. ChenLv Herb Corporation Information
Table 158. ChenLv Herb Description and Major Businesses
Table 159. ChenLv Herb L-Dopa Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 160. ChenLv Herb L-Dopa Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. ChenLv Herb Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. L-Dopa Distributors List
Table 165. L-Dopa Customers List
Table 166. L-Dopa Market Trends
Table 167. L-Dopa Market Drivers
Table 168. L-Dopa Market Challenges
Table 169. L-Dopa Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. L-Dopa Product Picture
Figure 2. Global L-Dopa Market Share by Type in 2021 & 2028
Figure 3. Purity: 98% Product Picture
Figure 4. Purity: 99% Product Picture
Figure 5. Global L-Dopa Market Share by Application in 2021 & 2028
Figure 6. Parkinson Disease Medicine
Figure 7. Hepatic Encephalopathy Medicine
Figure 8. Others
Figure 9. L-Dopa Report Years Considered
Figure 10. Global L-Dopa Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 11. Global L-Dopa Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 12. Global L-Dopa Production Market Share by Region (2017-2022)
Figure 13. Global L-Dopa Production Market Share by Region (2023-2028)
Figure 14. L-Dopa Production Growth Rate in North America (2017-2028) & (Tons)
Figure 15. L-Dopa Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 16. L-Dopa Production Growth Rate in China (2017-2028) & (Tons)
Figure 17. L-Dopa Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 18. Global L-Dopa Sales 2017-2028 (Tons)
Figure 19. Global L-Dopa Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 20. Global L-Dopa Revenue 2017-2028 (US$ Million)
Figure 21. Global L-Dopa Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 22. Global L-Dopa Sales Market Share by Region (2017-2022)
Figure 23. Global L-Dopa Sales Market Share by Region (2023-2028)
Figure 24. North America L-Dopa Sales YoY (2017-2028) & (Tons)
Figure 25. North America L-Dopa Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Europe L-Dopa Sales YoY (2017-2028) & (Tons)
Figure 27. Europe L-Dopa Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific L-Dopa Sales YoY (2017-2028) & (Tons)
Figure 29. Asia-Pacific L-Dopa Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Latin America L-Dopa Sales YoY (2017-2028) & (Tons)
Figure 31. Latin America L-Dopa Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Middle East & Africa L-Dopa Sales YoY (2017-2028) & (Tons)
Figure 33. Middle East & Africa L-Dopa Revenue YoY (2017-2028) & (US$ Million)
Figure 34. The L-Dopa Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 35. The Top 5 and 10 Largest Manufacturers of L-Dopa in the World: Market Share by L-Dopa Revenue in 2021
Figure 36. L-Dopa Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 37. Global L-Dopa Sales Market Share by Type (2017-2028)
Figure 38. Global L-Dopa Revenue Market Share by Type (2017-2028)
Figure 39. Global L-Dopa Sales Market Share by Application (2017-2028)
Figure 40. Global L-Dopa Revenue Market Share by Application (2017-2028)
Figure 41. North America L-Dopa Sales Market Share by Type (2017-2028)
Figure 42. North America L-Dopa Revenue Market Share by Type (2017-2028)
Figure 43. North America L-Dopa Sales Market Share by Application (2017-2028)
Figure 44. North America L-Dopa Revenue Market Share by Application (2017-2028)
Figure 45. North America L-Dopa Sales Share by Country (2017-2028)
Figure 46. North America L-Dopa Revenue Share by Country (2017-2028)
Figure 47. United States L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 48. Canada L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 49. Europe L-Dopa Sales Market Share by Type (2017-2028)
Figure 50. Europe L-Dopa Revenue Market Share by Type (2017-2028)
Figure 51. Europe L-Dopa Sales Market Share by Application (2017-2028)
Figure 52. Europe L-Dopa Revenue Market Share by Application (2017-2028)
Figure 53. Europe L-Dopa Sales Share by Country (2017-2028)
Figure 54. Europe L-Dopa Revenue Share by Country (2017-2028)
Figure 55. Germany L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 56. France L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 57. U.K. L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 58. Italy L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 59. Russia L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 60. Asia Pacific L-Dopa Sales Market Share by Type (2017-2028)
Figure 61. Asia Pacific L-Dopa Revenue Market Share by Type (2017-2028)
Figure 62. Asia Pacific L-Dopa Sales Market Share by Application (2017-2028)
Figure 63. Asia Pacific L-Dopa Revenue Market Share by Application (2017-2028)
Figure 64. Asia Pacific L-Dopa Sales Share by Region (2017-2028)
Figure 65. Asia Pacific L-Dopa Revenue Share by Region (2017-2028)
Figure 66. China L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 67. Japan L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 68. South Korea L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 69. India L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 70. Australia L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 71. China Taiwan L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 72. Indonesia L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 73. Thailand L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 74. Malaysia L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 75. Latin America L-Dopa Sales Market Share by Type (2017-2028)
Figure 76. Latin America L-Dopa Revenue Market Share by Type (2017-2028)
Figure 77. Latin America L-Dopa Sales Market Share by Application (2017-2028)
Figure 78. Latin America L-Dopa Revenue Market Share by Application (2017-2028)
Figure 79. Latin America L-Dopa Sales Share by Country (2017-2028)
Figure 80. Latin America L-Dopa Revenue Share by Country (2017-2028)
Figure 81. Mexico L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 82. Brazil L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 83. Argentina L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 84. Colombia L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 85. Middle East and Africa L-Dopa Sales Market Share by Type (2017-2028)
Figure 86. Middle East and Africa L-Dopa Revenue Market Share by Type (2017-2028)
Figure 87. Middle East and Africa L-Dopa Sales Market Share by Application (2017-2028)
Figure 88. Middle East and Africa L-Dopa Revenue Market Share by Application (2017-2028)
Figure 89. Middle East and Africa L-Dopa Sales Share by Country (2017-2028)
Figure 90. Middle East and Africa L-Dopa Revenue Share by Country (2017-2028)
Figure 91. Turkey L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 92. Saudi Arabia L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 93. UAE L-Dopa Revenue (2017-2028) & (US$ Million)
Figure 94. L-Dopa Value Chain
Figure 95. L-Dopa Production Process
Figure 96. Channels of Distribution
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed


★調査レポート[L-ドーパの世界市場インサイト・予測（～2028年）] (コード：QY22JLX01363)販売に関する免責事項を必ずご確認ください。
★調査レポート[L-ドーパの世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 医薬品用グルコサミンの世界市場インサイト・予測（～2028年）
  • 注射用医薬品添加剤の世界市場インサイト・予測（～2028年）
  • マルボフロキサシンの世界市場インサイト・予測（～2028年）
  • カンレノンの世界市場インサイト・予測（～2028年）
  • 多結晶ダイヤモンドスラリーの世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆